Zhengye Biotechnology Holding Limited (ZYBT)

ZYBT Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	23.53	9.75	6.28
Short-Term Investments	30.9	30.68	18.28
Cash & Cash Equivalents	54.43	40.43	24.56
Cash Growth	-	64.58%	-
Receivables	91.99	102.9	83.42
Inventory	53.98	55.42	43.62
Other Current Assets	16.51	15.56	13.34
Total Current Assets	216.92	214.31	164.94
Property, Plant & Equipment	-	275.17	246.34
Goodwill and Intangibles	-	27.96	20.82
Other Long-Term Assets	-	2.23	13.17
Total Long-Term Assets	-	305.37	280.34
Total Assets	-	519.67	445.28
Accounts Payable	-	79.28	77.57
Current Debt	-	54.89	30
Other Current Liabilities	-	18.06	18.06
Total Current Liabilities	-	152.23	125.63
Long-Term Debt	-	9.99	-
Other Long-Term Liabilities	-	0.59	0.82
Total Long-Term Liabilities	-	10.58	0.82
Total Liabilities	-	162.81	126.44
Total Debt	89.85	64.88	30
Debt Growth	-	116.27%	-
Retained Earnings	-	65.77	42.33
Shareholders' Equity	325.83	356.87	318.84
Net Cash / Debt	-35.42	-24.46	-5.44
Working Capital	-	62.08	39.32

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).